Table 1.
Cell line/cell | HLA-A2 | CML28 |
---|---|---|
K562 | − | + |
HL-60 | − | + |
HepG2 | + | + |
MCF-7 | + | + |
Patient 1 (AML) primary cells | + | + |
Patient 2 (CML) primary cells | + | − |
Patient 3 (CML) primary cells | + | + |
PBMCs from five donors | + | − |
Cell line/cell | HLA-A2 | CML28 |
---|---|---|
K562 | − | + |
HL-60 | − | + |
HepG2 | + | + |
MCF-7 | + | + |
Patient 1 (AML) primary cells | + | + |
Patient 2 (CML) primary cells | + | − |
Patient 3 (CML) primary cells | + | + |
PBMCs from five donors | + | − |